The FDA can accelerate progress if the drug addresses an unmet need or demonstrates significant benefit over existing therapies
concomitant antidiabetic medications (biguanides, sulfonylureas, alpha-glucosidase inhibitors, thiazolidinediones, dipeptidyl peptidase-4 inhibitors [DPP-4i], insulin)
Our nurse practitionerled program emphasizes education, personalized care, and habit-building so patients dont just lose weight, but learn how to maintain their results long after treatment
Youll hear two clicks: the first tells you the injection started, and the second tells you the injection is complete
Primary Handling Editors: Yanina-Yasmin Pesch and Alfredo Gimenez-Cassina, in collaboration with the Nature Metabolism team